B. Patachi, K. H. Jensen, A. Gothelf, M. Bernsdorf, J. Friborg, and C. A. Kristensen, “Pembrolizumab as first-line treatment for recurrent and metastatic head and neck cancer – real-world single-centre data”, AO, vol. 64, pp. 143–146, Jan. 2025.